You are viewing the "Pfizer" Archives
WASHINGTON, D.C. (NPR) — Children ages 5 through 11 who’ve received two shots of the Pfizer COVID-19 vaccine may soon be eligible for a booster. That’s if the Food and Drug Administration agrees to a request made Tuesday by pharmaceutical companies Pfizer and BioNTech to authorize their booster shot for kids in this age range…. Read More
WASHINGTON, D.C. (AP) — U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine. The Food and Drug Administration’s decision aims to offer extra protection to the most vulnerable in case the virus rebounds. The FDA said Tuesday that age group can seek a fourth dose… Read More
WASHINGTON, D.C. (NPR) — People who were initially immunized with two shots of the Pfizer-BioNTech COVID-19 vaccine should receive a booster shot after five months, rather than six, according to a new recommendation from the the Centers for Disease Control and Prevention. The move comes after the Food and Drug Administration on Monday authorized the… Read More
Updated January 3, 2022 at 10:41 AM ET WASHINGTON, D.C. (NPR) — The Food and Drug Administration has authorized the use of a Pfizer-BioNTech booster in adolescents 12 to 15 years old. The agency on Monday also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose… Read More
WASHINGTON, D.C. (NPR) — The Food and Drug Administration has authorized a Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11. This lower-dose formulation of the companies’ adult vaccine was found to be safe and 90.7% effective in preventing COVID-19. The agency acted Friday after a panel of independent scientists advising the FDA strongly supported… Read More
Updated October 7, 2021 at 9:27 AM ET WASHINGTON, D.C. (NPR) — Pfizer and BioNTech are officially asking the Biden administration to authorize the use of their COVID-19 vaccine for children ages 5 to 11. Pfizer tweeted on Thursday that the companies had submitted their formal request for Emergency Use Authorization of the vaccine to… Read More
WASHINGTON, D.C. (NPR) — Pfizer and BioNTech are another step closer to seeking authorization for young children to receive the COVID-19 coronavirus vaccine, submitting data to the Food and Drug Administration that shows a “robust” antibody response and “favorable” safety outcomes in kids ages 5 to 11 who received the two-dose regimen in clinical trials…. Read More
ATHENS, Ohio (WOUB) — Ohio University is switching to the Pfizer COVID-19 vaccine for its student clinics after federal officials recommended a temporary halt in use of the Johnson & Johnson vaccine for safety reasons. Also, because the Pfizer vaccine requires two doses three weeks apart, students will be allowed to get one of the… Read More
Pfizer says it will submit the clinical trial results “as soon as possible” to the U.S. Food and Drug Administration, and is hoping to start vaccinating children before the next school year.
The new deal effectively doubles the federal government’s order from the company. Pfizer said the U.S. government has agreed to pay $1.95 billion for the additional doses.
WASHINGTON (AP) — A U.S. government advisory panel has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. The group, in a 17-4 vote with one abstention, concluded… Read More
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
Pfizer’s COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.
If the company’s vaccine candidate pans out, Americans can receive it for free, under the deal. The arrangement is part of the U.S. government’s push to have a vaccine widely available by January.